Start-up Slams – Confirmation

Home » Pitch Sessions » Start-up Slams – Confirmation

Thank you for your application!

Your application for the BioFIT 2026 Start-up Slams has been successfully submitted and will now enter the preliminary selection process.
We will keep you informed and notify you shortly whether your application has been selected to proceed to the final stage of the selection process.

What happens next?

Your application will go through a two-step selection process led by an international jury of Life Sciences experts.

Step 1 | Preliminary selection
All applications are reviewed by the jury. The most promising projects are shortlisted for the final selection.
All applicants receive feedback from the jury, whether selected or not.

↓

Step 2 | Final selection
Due to the limited number of presentation slots available at BioFIT, the jury scores each shortlisted application and selects the highest-rated projects to pitch live at the event.

Have you registered for BioFIT yet?

Submitting an application to the Start-up Slams does not automatically register you for BioFIT 2026.

If your application is selected, all team members attending BioFIT, including the person presenting the innovation on stage, must be registered for the event.

Don’t wait until the last minute, secure your place today.

Hear from previous BioFIT pitchers

“Winning at BioFIT created more visibility for Klasther and gave confidence to the team that we are on the right track. It also encouraged investors to continue discussion with Klasther.”
Paolo Michieli, Founder and CEO, Klasther Biopharma

”Winning at BioFIT brings valuable visibility, credibility, and momentum to our work. It truly means a great deal to us: after years of intense R&D and development, this was the very first time we publicly presented our project. Receiving such recognition from an international jury is incredibly encouraging. It validates our scientific and clinical vision and energizes our discussions with partners, investors, and regulatory agencies. It also opens new doors within the animal health ecosystem, which is invaluable as we move toward our next clinical and regulatory milestones.”
Pascal Surugue, Co-founder & CEO, iC Biosolutions